Evidence map›Paper›PMID 40999362›Full record

ArticleBMC nephrology2025

Role of SAA1 in mediating renal fibrosis through TLR4-dependent NF-κB activation.

Xiao Wei, Lixiang Feng, Yuan Yuan, Qihui Kuang, Hong Yu, Jun Yang, Xiong Wang, Pengcheng Luo

Abstract read
In one paragraph

Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiao Wei *Department of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, 430060, China.
Lixiang Feng *Department of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, 430060, China.
Yuan Yuan *Department of Urology, The Affiliated Panyu Central Hospital, Guangzhou Medical University, Guangzhou, 510000, China.
Qihui KuangDepartment of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, 430060, China.
Hong YuDepartment of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, 430060, China.
Jun YangDepartment of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, 430060, China. 735291410@qq.com.
Xiong WangDepartment of Pharmacy, Wuhan Third Hospital, Wuhan, 430060, China. wangxiong-133494@163.com.
Pengcheng LuoDepartment of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, 430060, China. pluo@whu.edu.cn.

Funding

National Key Research and Development Program of China 2023YFC3605500Wuhan Application Foundation and Frontier Project 2020020601012209
6 · The paper itself

Abstract

backgroundRenal fibrosis is a key and irreversible pathological event in the progression of chronic kidney disease (CKD), and inflammatory response plays an important role in this process. Serum amyloid A1 (SAA1), an acute-phase reactant protein, which plays an important role in inflammation as a cytokine; but its specific role in renal fibrosis remains to be studied.

methodsIn this study, SAA1 and TLR4 knockout mice were used to establish unilateral ureteral obstruction (UUO) animal renal fibrosis model, and HK-2 cells were used to establish TGF-β-induced cell fibrosis model. The specific role of SAA1 in renal fibrosis was explored by immunoblotting and immunohistochemistry. Subsequently, this study used molecular docking and Co-Immunoprecipitation to verify the specific mechanism of SAA1 promoting renal fibrosis progression.

resultsWe found that SAA1 levels were significantly increased in both in vivo and in vitro fibrosis models. Functional studies have shown that gene knockout or knockdown of SAA1 can significantly reduce the progression of renal fibrosis and limited fibrin deposition. On the contrary, overexpression of SAA1 in HK-2 cells aggravated the process of fibrosis. At the mechanism level, we found that in HK-2 cells, SAA1 can directly bind to TLR4, activate downstream NF-κB signaling pathway, promote the production of various cytokines, and then promote the progress of renal fibrosis. Importantly, knockdown of TLR4 alleviated this process.

conclusionsThis study demonstrates that SAA1 promotes the progression of renal fibrosis through TLR4/NF-κB signaling pathway.

Indexed as

KidneyNF-kappa BSerum Amyloid A ProteinToll-Like Receptor 4AnimalsCell LineFibrosisHumansMaleMiceMice, Inbred C57BLMice, KnockoutRenal Insufficiency, ChronicSignal TransductionUreteral ObstructionNF-kappa BSAA1 protein, humanSerum Amyloid A ProteinTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4CKDInflammatory responseNF-κB signaling pathwayRenal fibrosisSAA1TLR4

Identifiers

PMID40999362
PMCPMC12465874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.